Vor Biopharma Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vor Biopharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Vor Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.79M, a 34.1% decline year-over-year.
  • Vor Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $10.9M, a 29.5% decline year-over-year.
  • Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.4M, a 24.9% increase from 2022.
  • Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.7M, a 148% increase from 2021.
  • Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.32M, a 222% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.4M +$2.67M +24.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $10.7M +$6.38M +148% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $4.32M +$2.97M +222% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $1.34M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.